A patient is newly diagnosed with HIV and has a history of previously receiving cabotegravir for preexposure prophylaxis. Results from a standard genotype resistance assay and integrase resistance genotype are pending.
Which one of the initial antiretroviral regimens listed below is indicated if starting therapy before the genotype results return?

Dolutegravir plus tenofovir DF-emtricitabine

Darunavir-cobicistat-tenofovir alafenamide-emtricitabine

Doravirine-tenofovir DF-emtricitabine

Bictegravir-tenofovir alafenamide-emtricitabine